After developing a breakthrough vaccine with the financial and scientific support of the US government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer
FILE — A nurse carries out trials of a COVID-19 vaccine at the Desmond Tutu HIV Foundation Youth Center in Masiphumelele, South Africa, Dec. 4, 2020. Moderna, whose coronavirus vaccine was developed with the financial and scientific support of the US government, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit. Photo by Joao Silva/The New York Times
©2019 New York Times News Service